Effect of amodiaquine, a histamine N-methyltransferase inhibitor, on, Propionibacterium acnes and lipopolysaccharide-induced hepatitis in mice

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 179-184

  Yokoyama, Akira ^a   Mori, Shuji ^a   Takahashi, Hideo K ^a   Kanke, Toru ^a   Wake, Hidenori ^a   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Amodiaquine; Hepatitis; Lipopolysaccharide; Propionibacterium acnes

Indexed keywords

ALANINE AMINOTRANSFERASE; AMODIAQUINE; ASPARTATE AMINOTRANSFERASE; ENDOTOXIN; GAMMA INTERFERON; HISTAMINE; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; MESSENGER RNA; METHYLTRANSFERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BLOOD LEVEL; GENE EXPRESSION; HEPATITIS; HISTAMINE BLOOD LEVEL; LIVER; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE;

ALANINE TRANSAMINASE; AMODIAQUINE; ANIMALS; ASPARTATE AMINOTRANSFERASES; ENZYME INHIBITORS; HEPATITIS, TOXIC; HISTAMINE; HISTAMINE N-METHYLTRANSFERASE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; PROPIONIBACTERIUM ACNES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847326203     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.033     Document Type: Article

References (35)

1. Arrang J.M., Garbarg M., and Schwartz J.C. Auto-inhibitor of brain histamine release mediated by novel class (H3) of histamine receptor. Nature 302 (1983) 832-837
2. Barth H., Lorentz W., and Troidl H. Effect of amodiaquine on gastric histamine methyltransferase and on histamine-stimulated gastric section. Br. J. Pharmacol. 55 (1975) 321-327
3. Black J.W., Duncan W.J., Durant C.J., Ganellin C.R., and Parson E.M. Definition and antagonism of histamine H2-receptor. Nature 236 (1972) 385-390
4. Clarke J.B., Neftel K., Kitteringham N.R., and Park B.K. Detection of antidrug IgG antibodies in patients with adverse drug reaction to amodiaquine. Int. Arch. Allergy Appl. Immunol. 95 (1991) 369-375
5. Cleaveland J.L., and Ihle J.N. Contenders in Fas/TNF death signaling. Cell 814 (1995) 479-482
6. Dell Valle J., and Gantz I. Novel insights into histamine H2 receptor biology. Am. J. Physiol. 273 (1997) 987-996
7. Fraser A., and Evan G. A license to kill. Cell 8 (1996) 781-784
8. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., Krammer P.H., and Runkel L. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182 (1995) 1223-1230
9. Hill S.J., Ganellin C.R., Timmerman H., Shankley J.C., and Young N.P. International union of pharmacology XIII. Classification of histamine receptors. Pharmacol. Rev. 49 (1997) 253-278
10. Hofstra C.L., Desai P.J., Thurmond R.L., and Wai-Ping Fung-Leung W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305 (2003) 1212-1221
11. Hornyak S.C., Gehlsen K.R., and Haaparanta T. Histamine dihydrochloride protect against early alcohol-induced liver injury in a rat model. Inflammation 27 (2003) 317-326
12. Horton J.R., Sawada K., Nishibori M., and Cheng X. Structural basis for inhibitor of histamine N-methyltransferase by diverse drugs. J. Mol. Biol. 353 (2005) 334-344
13. Hough L.B. Genomics meets histamine receptors: new subtypes, new receptors. Mol. Pharmacol. 59 (2001) 415-419
14. Hsu H., Xlong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81 (1995) 495-504
15. Itoh Y., Oishi R., Adachi N., and Saeki K. A highly sensitive assay for histamine using ion-pair HPLC coupled with postcolumn fluorescent derivatization: its application to biological specimens. J. Neurochem. 58 (1992) 884-889
16. Katschinski T., Galanos C., Coumbos A., and Freudenberg M.A. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60 (1992) 1994-2001
17. Kitanaka N., Kitanaka J., Oue T., and Tada Y. Genomic structure of the rat and mouse histamine N-methyltransferase gene. Jpn. J. Pharmacol. 88 (2002) 85-92
18. Morichika T., Takahashi H.K., Iwagaki H., Yoshino T., Tamura R., Yokoyama M., Mori S., Akagi T., Nishibori M., and Tanaka N. Histamine inhibits lipopolysaccharide-induced tumor necrosis factor-α production in an intercellular adhesion molecule-1- and B7.1-dependent manner. J. Pharmacol. Exp. Ther. 304 (2003) 624-633
19. Nishibori M., Oishi R., and Saeki K. Histamine turnover in the brain of different mammalian species: implications for neuronal histamine half-life. J. Neurochem. 43 (1984) 1544-1549
20. Nishibori M., Tahara A., Sawada K., Sakiyama J., Nakaya N., and Saeki K. Neuronal and vascular localization of histamine N-methyltransferase in the bovine central nervous system. Eur. J. Neurosci. 12 (2000) 415-424
21. Okamura H., Tsutsi H., Komathu T., Yutsudo M., Hakura A., Tanimoto T., Trigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., and Kurimoto M. Cloning of a new cytokine that induces IFN-g production by T cells. Nature 378 (1995) 88-91
22. Panny G.C., and Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transduction. J. Immunol. 159 (1997) 5450-5456
23. Schayer R.W. Catabolism of physiological quantities of histamine in vivo. Physiol. Rev. 39 (1959) 116-120
24. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., and Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71 (1991) 1-51
25. Schwelberger H.G. Histamine N-methyltransferase (HNMT) enzyme and gene. In: Falus A., Grosman N., and Darvas Z.S. (Eds). Histamine N-Methyl-Transferase. Enzymology and Functional Aspects (2004), SpringMed Publishing Ltd/S. Karger AG, Budapest/Basel 53-59
26. Smith S.R., Calzetta A., Bankowski J., Kenworthy-Bott L., and Terminelli C. Li-popolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J. Leukoc. Biol. 54 (1993) 23-29
27. Tahara A., Nishibori M., Ohtsuka A., Sawada K., Sakiyama J., and Saeki K. Immunohistochemical localization of histamine N-methyltransferase in guinea pig tissue. J. Histochem. Cytochem. 48 (2000) 943-954
28. Takahashi H.K., Morichika T., Iwagaki H., Tamura R., Kubo S., Yoshino T., Mori S., Akagi T., Tanaka N., and Nishibori M. Histamine downregulates CD14 expression via H2 receptors on human monocytes. Clin. Imuunol. 108 (2003) 274-281
29. Thurmond R.L., Desai P.J., Dunford P.J., Fung-Leung W.P., Hofstra C.L., and Jiang W. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 309 (2004) 404-413
30. Tsutsui H., Matsui K., Kawada N., Hyodo Y., Hayashi N., Okamura H., Higashino K., and Nakanishi K. IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159 (1997) 3961-3967
31. Tsuji H., Harada A., Mukaida N., Nakanuma Y., Bluethmann H., Kaneko S., Yamak-awa K., Nakamura S.I., Kobayashi K.I., and Matsushima K. Tumor necrosis factor receptor p55 is essential for intrahepatic granuloma formation and hepatocellular apoptosis in a murine model of bacterium-induced fulminant hepatitis. Infect. Immun. 65 (1997) 1892-1898
32. Tsuji H., Mukaida N., Harada A., Kaneko S., Matsushita E., Nakanuma Y., Tsutsui H., Okamura H., Nakanishi K., Tagawa Y., Iwakura Y., Kobayashi K., and Matsushima K. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production. J. Immunol. 162 (1999) 1049-1055
33. Verburg K.M., and Henry D.P. Histamine N-methyltransferase. Enzymology and functional aspects. In: Boulton A.A., Baker G.B., and Yu P.H. (Eds). Histamine Receptors: Specific Ligands, Receptor Biochemistry, and Signal Transduction (1986), Humana Press, Clifton, NJ 147-204
34. Yokoyama M., Yokoyama A., Mori S., Takahasi H., Yoshino T., Watanabe T., Ohtsu H., and Nishibori M. Indusible histamine protect mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroentelogy 127 (2004) 892-902
35. Yoneyama H., Harada A., Imai T., Baba M., Yoshie O., Zhang Y., Higashi H., Murai M., Asakura H., and Matsushima K. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J. Clin. Invest. 102 (1998) 1933-19-1933-41